Velcade bortezomib: Phase II data

Data from a U.K. Phase II trial in 39 evaluable patients with relapsed

Read the full 134 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE